In November 2010, GeneGo Inc was acquired by Thomson Reuters. GeneGo, Inc. provides data mining and analysis solutions in systems biology. It offers MetaCore, a database and software suite for pathway analysis of experimental data/gene lists; MetaDrug, a systems pharmacology platform for evaluating biological effects of small molecule compounds on the human body; and Eureka! that provides chemistry, biology, disease, and pathway-searching knowledge mining tools. The company also provides MC/MD Discovery Platform, a systems biology and pathway analysis solution for analyzing data generated by biology and chemistry experiments; MetaBase, which includes a manually curated source of mammalian biology and medicinal chemistry data; and MapEditor, a software tool for custom editing of canonical pathway maps and conversion into map views. In addition, it offers MetaMiner that provides knowledge mining and data analysis platforms; MetaMiner (Stem Cells) that reconstructs pathway maps for stem cell science, including oncology and neurology; MetaMiner Prostate Cancer, a platform that extends the application of MetaDiscovery platforms to include canonical pathway maps and networks specific for disease; and MetaMiner Cystic Fibrosis, a data analysis platform. Further, the company provides System Toxicology Module, which includes ToxHunter, a systems toxicology knowledgebase/data analysis package; and DataRanger that obtains the components of the data and statistically processes the files. Furthermore, it provides contract research/knowledge management, toxicology, and training services. The company serves life science, pharmaceutical, and biotech companies; and governments, universities, and research institutions in the United States, Europe, and Asia. GeneGo, Inc. was founded in 2000 and is headquartered in St. Joseph, Michigan with offices in San Diego, California; and Moscow, Russian Federation.
